Codetection of a mixed population of candHPV62 containing wild-type and disrupted E1 open-reading frame in a 45-year-old woman with normal cytology

Journal of Infectious Diseases

Volumn 190, Issue 7, 2004, Pages 1303-1309

  Fu, Leiping ^a   Terai, Masanori ^a,d   Matsukura, Toshihiko ^b   Herrero, Rolando ^c   Burk, Robert D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c Proyecto Epidemiologico Guanacaste   (Costa Rica)

^d NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; CYTOLOGY; DATA BASE; FEMALE; FRAMESHIFT MUTATION; GENE DISRUPTION; GENE E1; GENE SEQUENCE; GENETIC COMPLEMENTATION; HUMAN; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; UTERINE CERVIX TUMOR; VIRUS GENE; VIRUS GENOME; VIRUS STRAIN; WART VIRUS;

BASE SEQUENCE; CERVIX UTERI; CLONING, MOLECULAR; FEMALE; GENOME, VIRAL; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; PAPILLOMAVIRIDAE;

EID: 4644247492     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/423855     Document Type: Article

References (36)

1. Schiffman MH, Burk RD. Human papillomaviruses. In: Evans AS, Kaslow R, eds. Viral infections of humans: epidemiology and control. 4th ed. New York: Plenum, 1997:983-1023.
2. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995; 87:796-802.
3. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348:518-27.
4. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology 2004; 324:17-27.
5. Bernard HU, Chan SY, Manos MM, et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 1994; 170: 1077-85.
6. Herrero R, Hildesheim A, Bratti C, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000; 92:464-74.
7. Peyton CL, Gravitt PE, Hunt WC, et al. Determinants of genital human papillomavirus detection in a US population. J Infect Dis 2001; 183: 1554-64.
8. Terai M, Burk RD. Identification and characterization of 3 novel genital human papillomaviruses by overlapping polymerase chain reaction: candHPV89, candHPV90, and candHPV91. J Infect Dis 2002; 185:1794-7.
9. Terai M, Burk RD. Characterization of a novel genital human papillomavirus by overlapping PCR: candHPV86 identified in cervicovaginal cells of a woman with cervical neoplasia. J Gen Virol 2001; 82:2035-40.
10. Terai M, Burk RD. Complete nucleotide sequence and analysis of a novel human papillomavirus (HPV 84) genome cloned by an overlapping PCR method. Virology 2001; 279:109-15.
11. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997; 25:4870-82.
12. Swofford D. PAUP*: Phylogenetic analysis using parsimony (* and other methods). Version 4.0. Sunderland, MA: Sinauer Associates, 2002.
13. Gallahan D, Muller M, Schneider A, et al. Human papillomavirus type 53. J Virol 1989; 63:4911-2.
14. Lorincz AT, Quinn AP, Goldsborough MD, McAllister P, Temple GF. Human papillomavirus type 56: a new virus detected in cervical cancers. J Gen Virol 1989; 70:3099-104.
15. Volter C, He Y, Delius H, et al. Novel HPV types present in oral papillomatous lesions from patients with HIV infection. Int J Cancer 1996; 66:453-6.
16. Burk RD, Ho GYF, Beardsley L, Lempa M, Peters M, Bierman R. Sexual practices and partner selection are the predominant risk factors for genital HPV infection in young women. J Infect Dis 1996; 174:679-89.
17. Palefsky JM, Minkoff H, Kalish LA, et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 1999; 91: 226-36.
18. Chan SY, Delius H, Halpern AL, Bernard HU. Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy. J Virol 1995; 69:3074-83.
19. Seedorf K, Krammer G, Durst M, Suhai S, Rowekamp WG. Human papillomavirus type 16 DNA sequence. Virology 1985; 145:181-5.
20. Matsukura T, Kanda T, Furuno A, Yoshikawa H, Kawana T, Yoshiike K. Cloning of monomeric human papillomavirus type 16 DNA integrated within cell DNA from a cervical carcinoma. J Virol 1986; 58:979-82.
21. Qu W, Jiang G, Cruz Y, et al. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 1997; 35:1304-10.
22. Strickler HD, Palefsky JM, Shah KV, et al. Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst 2003; 95:1062-71.
23. Tachezy R, Van Ranst MA, Cruz Y, Burk RD. Analysis of short novel human papillomavirus sequences. Biochem Biophys Res Commun 1994; 204:820-7.
24. Peyton CL, Wheeler CM. Identification of five novel human papillomavirus sequences in the New Mexico triethnic population. J Infect Dis 1994; 170:1089-92.
25. Manos MM, Waldman J, Zhang TY, et al. Epidemiology and partial nucleotide sequence of four novel genital human papillomaviruses. J Infect Dis 1994; 170:1096-9.
26. Brown DR, McClowry TL, Woods K, Fife KH. Nucleotide sequence and characterization of human papillomavirus type 83, a novel genital papillomavirus. Virology 1999; 260:165-72.
27. Menzo S, Monachetti A, Trozzi C, et al. Identification of six putative novel human papillomaviruses (HPV) and characterization of candidate HPV type 87. J Virol 2001; 75:11913-9.
28. Kim K, Lambert PF, E1 protein of bovine papillomavirus 1 is not required for the maintenance of viral plasmid DNA replication. Virology 2002; 293:10-4.
29. Seedorf K, Oltersdorf T, Krammer G, Rowekamp W. Identification of early proteins of the human papilloma viruses type 16 (HPV 16) and type 18 (HPV 18) in cervical carcinoma cells. Embo J 1987; 6:139-44.
30. Wang Q, Griffin H, Southern S, et al. Functional analysis of the human papillomavirus type 16 E1∧E4 protein provides a mechanism for in vivo and in vitro keratin filament reorganization. J Virol 2004; 78:821-33.
31. Brown DR, Bryan J, Rodriguez M, Rose RC, Strike DG. Detection of human papillomavirus types 6 and 11 E4 gene products in condylomata acuminatum. J Med Virol 1991; 34:20-8.
32. Chow LT, Nasseri M, Wolinsky SM, Broker TR. Human papillomavirus types 6 and 11 mRNAs from genital condylomata acuminata. J Virol 1987; 61:2581-8.
33. Pray TR, Laimins LA. Differentiation-dependent expression of E1-E4 proteins in cell lines maintaining episomes of human papillomavirus type 31b. Virology 1995; 206:679-85.
34. Mendell JT, Dietz HC. When the message goes awry: disease-producing mutations that influence mRNA content and performance. Cell 2001; 107:411-4.
35. Deng W, Jin G, Lin BY, Van Tine BA, Broker TR, Chow LT. mRNA splicing regulates human papillomavirus type 11 E1 protein production and DNA replication. J Virol 2003; 77:10213-26.
36. Lee JH, Yi SM, Anderson ME, et al. Propagation of infectious human papillomavirus type 16 by using an adenovirus and Cre/LoxP mechanism. Proc Natl Acad Sci USA 2004; 101:2094-9.